Shineco and Plus Me Sign Cooperation Agreement

Written by Emily J. Thompson, Senior Investment Analyst

SISI%

Updated: Aug 20 2025

0mins

Partnership Announcement: Shineco has entered into a cooperation agreement with Plus Me Limited to create a blockchain-based ecosystem for tokenizing biological cellular assets.
Blockchain Implementation: The partnership will facilitate global transfers and standardized custody of mesenchymal stem cells using the Ethereum mainnet, ensuring secure ownership through smart contracts.
Asset Traceability: Each cellular asset will receive a non-fungible digital identifier, enhancing traceability and compliance via cryptographic enforcement and on-chain hashing.
Strategic Acquisition: Shineco has acquired a 51% stake in Xi'an Dong'ao Health Management, which specializes in cryogenic cell storage, providing essential off-chain infrastructure for token redemption.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Shineco and Plus Me Sign Cooperation Agreement

About the author

Top News

Oil Firms Cautious on Venezuela Investment Push

GM Reports $7.1 Billion Charge Amid EV Shift

Stock Market Wraps 2025 with Double-Digit Gains

Novo Nordisk's Weight-Loss Pill Approval: Key Impacts

Related Articles

Rosen Law Firm Alerts on Sprouts Farmers Market Class Action Deadline

Rosen Law Firm Investigates Potential Securities Claims for America's Car-Mart Shareholders

Sigh Up to Get Intellectia Insights

How did the company's recent strategic decisions impact its latest financial performance?

Can you explain the factors behind the recent changes in the company's stock price?

What are the expected impacts of current market trends on the company's future growth?

Based on the latest earnings report, what are the company's forecasted revenues for the next quarter?

How does the company's performance compare to its main competitors in the same sector?

People Also Watch